Dietary Guidance From the International Organization for the Study of Inflammatory Bowel Diseases

Arie Levine, Jonathan M. Rhodes, James O. Lindsay, Maria T. Abreu, Michael A. Kamm, Peter R. Gibson, Christoph Gasche, Mark S. Silverberg, Uma Mahadevan, Rotem Sigall Boneh, Eyton Wine, Oriana M. Damas, Graeme Syme, Gina L. Trakman, Chu Kion Yao, Stefanie Stockhamer, Muhammad B. Hammami, Luis C. Garces, Gerhard Rogler, Ioannis E. KoutroubakisAshwin N. Ananthakrishnan, Liam McKeever, James D. Lewis*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

Abstract

Recent evidence points to a plausible role of diet and the microbiome in the pathogenesis of both Crohn's disease (CD) and Ulcerative Colitis (UC). Dietary therapies based on exclusion of table foods and replacement with nutritional formulas and/or a combination of nutritional formulas and specific table foods may induce remission in CD. In UC, specific dietary components have also been associated with flare of disease. While evidence of varying quality has identified potential harmful or beneficial dietary components, physicians and patients at the present time do not have guidance as to which foods are safe, may be protective or deleterious for these diseases. The current document has been compiled by the nutrition cluster of the International Organization for the Study of Inflammatory Bowel Diseases (IOIBD) based on the best current evidence to provide expert opinion regarding specific dietary components, food groups and food additives that may be prudent to increase or decrease in the diet of patients with inflammatory bowel diseases to control and prevent relapse of inflammatory bowel diseases.

Original languageEnglish
Pages (from-to)1381-1392
Number of pages12
JournalClinical Gastroenterology and Hepatology
Volume18
Issue number6
DOIs
StatePublished - May 2020

Funding

FundersFunder number
Arena Pharmaceuticals
GI Health Foundation
Nestle Health Science
Nestle Health Sciences
Pharmacosmos
SERES
Samsung Bioepis
Yakult Australia
Eli Lilly and Company
Pfizer
Roche
Samsung
Gilead Sciences
Janssen Biotech
Allergan Foundation
Celgene
AbbVie
Meso Scale Diagnostics
Shire
Takeda Pharmaceuticals U.S.A.
Takeda Pharmaceutical Company
Nestlé Health Science
School of Public Health, University of California Berkeley
Shire

    Keywords

    • Crohn's Disease
    • Food Additives
    • Fruit
    • Meat
    • Ulcerative Colitis
    • Vegetables

    Fingerprint

    Dive into the research topics of 'Dietary Guidance From the International Organization for the Study of Inflammatory Bowel Diseases'. Together they form a unique fingerprint.

    Cite this